Results 181 to 190 of about 5,151 (200)

Physico-chemical properties and thermal stability of microcrystalline cellulose isolated from Alfa fibres

Carbohydrate Polymers, 2014
Djalal Trache, Kamel Khimeche, Nicolas Brosse   +2 more
exaly  

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

New England Journal of Medicine, 2002
Michael W Fried, K Rajender Reddy, Dieter Häussinger   +2 more
exaly  

Darbepoetin-alfa/pacritinib/ruxolitinib

Reactions Weekly, 2021
openaire   +1 more source

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

Lancet, The, 2007
Simon Nadel, Mark John Peters
exaly  

Darbepoetin alfa.

2011
openaire   +1 more source

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Journal of Clinical Oncology, 2009
Robert J Motzer, Thomas E Hutson, C?zary A Szczylik   +2 more
exaly  

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

Lancet, The, 2023
exaly  

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study

Lancet Infectious Diseases, The, 2014
Ali S Omrani, Kamran Baig, Ziad Ahmed Memish   +2 more
exaly  

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
exaly  

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

The Lancet Gastroenterology and Hepatology, 2017
Valentin Cebotarescu, Lilia Cojuhari, Emmanuel Gordien   +2 more
exaly